XLO Xilio Therapeutics
- 1.240
- -0.020-1.59%
Xilio Therapeutics News
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Russo Rene
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Frankenfield Christopher James
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Kevin M.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina
Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(19.9%)
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(8.71%),Rock Springs Capital LLC(8.71%), etc.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund XI, L.P.
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%), etc.
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%), etc.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund XI, L.P.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Frankenfield Christopher James
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Kevin M.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Russo Rene
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina
Xilio Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Luptakova Katarina
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-CEO Russo Rene
Analysis
Price Target
No Data
